Oral albendazole for the treatment of cutaneous larva migrans

Publisher Website
Google Scholar
Abstract
Cutaneous larva migrans is becoming more common in the U.K. with popularity of tropical countries as holiday destinations. We describe the increasing use of a new benzimidazole derivative, albendazole, which is very effective in the treatment of cutaneous larva migrans. In contrast to thiabendazole, it is virutally free from side-effects and should, we feel, become the treatment of choice for this condition.

This publication has 4 references indexed in Scilit: